标题/作者	年份
Extrapulmonary manifestations of COVID-19 A Gupta, MV Madhavan, K Sehgal, N Nair, S Mahajan, TS Sehrawat, ... Nature medicine 26 (7), 1017-1032	2020
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 Y Huang, C Yang, X Xu, W Xu, S Liu Acta Pharmacologica Sinica 41 (9), 1141-1149	2020
The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity Q Li, J Wu, J Nie, L Zhang, H Hao, S Liu, C Zhao, Q Zhang, H Liu, L Nie, ... Cell 182 (5), 1284-1294. e9	2020
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike L Liu, P Wang, MS Nair, J Yu, M Rapp, Q Wang, Y Luo, JFW Chan, V Sahi, ... Nature 584 (7821), 450-456	2020
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2 X Chi, R Yan, J Zhang, G Zhang, Y Zhang, M Hao, Z Zhang, P Fan, ... Science 369 (6504), 650-655	2020
Mechanisms of SARS-CoV-2 entry into cells CB Jackson, M Farzan, B Chen, H Choe Nature reviews Molecular cell biology 23 (1), 3-20	2022
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2 R Shi, C Shan, X Duan, Z Chen, P Liu, J Song, T Song, X Bi, C Han, L Wu, ... Nature 584 (7819), 120-124	2020
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies A Baum, BO Fulton, E Wloga, R Copin, KE Pascal, V Russo, S Giordano, ... Science 369 (6506), 1014-1018	2020
SARS-CoV-2 501Y. V2 escapes neutralization by South African COVID-19 donor plasma CK Wibmer, F Ayres, T Hermanus, M Madzivhandila, P Kgagudi, ... Nature medicine 27 (4), 622-625	2021
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies CO Barnes, CA Jette, ME Abernathy, KMA Dam, SR Esswein, HB Gristick, ... Nature 588 (7839), 682-687	2020
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability PJM Brouwer, TG Caniels, K van der Straten, JL Snitselaar, Y Aldon, ... Science 369 (6504), 643-650	2020
Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology L Piccoli, YJ Park, MA Tortorici, N Czudnochowski, AC Walls, ... Cell 183 (4), 1024-1042. e21	2020
COVID-19: The first documented coronavirus pandemic in history YC Liu, RL Kuo, SR Shih Biomedical journal 43 (4), 328-333	2020
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2 Y Wu, F Wang, C Shen, W Peng, D Li, C Zhao, Z Li, S Li, Y Bi, Y Yang, ... Science 368 (6496), 1274-1278	2020
Distinct conformational states of SARS-CoV-2 spike protein Y Cai, J Zhang, T Xiao, H Peng, SM Sterling, RM Walsh Jr, S Rawson, ... Science 369 (6511), 1586-1592	2020
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity L Zhang, CB Jackson, H Mou, A Ojha, H Peng, BD Quinlan, ... Nature communications 11 (1), 6013	2020
Structures and distributions of SARS-CoV-2 spike proteins on intact virions Z Ke, J Oton, K Qu, M Cortese, V Zila, L McKeane, T Nakane, J Zivanov, ... Nature 588 (7838), 498-502	2020
Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection B Diao, C Wang, R Wang, Z Feng, J Zhang, H Yang, Y Tan, H Wang, ... Nature communications 12 (1), 2506	2021
SARS-CoV-2: structure, biology, and structure-based therapeutics development MY Wang, R Zhao, LJ Gao, XF Gao, DP Wang, JM Cao Frontiers in cellular and infection microbiology 10, 587269	2020
Molecular architecture of the SARS-CoV-2 virus H Yao, Y Song, Y Chen, N Wu, J Xu, C Sun, J Zhang, T Weng, Z Zhang, ... Cell 183 (3), 730-738. e13	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。